Description What is Oral BPC-157? This is an oral tablet formulation of BPC-157 — the same 15 amino acid repair peptide derived from human gastric juice described in our injectable BPC-157 listing. What makes oral BPC-157 particularly interesting is that most peptides are destroyed by stomach acid, making oral delivery impossible. BPC-157 is a rare exception — because it originates from a protein found in gastric juice, it has an unusual natural stability in acidic conditions. This means it can survive the stomach environment and maintain its biological activity when taken orally. What Researchers Are Exploring All the repair and recovery research areas described for injectable BPC-157 apply — tissue healing, inflammation, gut health, angiogenesis, and neuroprotection. The oral format adds specific interest: Gut Health (Direct Oral Contact) Oral BPC-157 delivers the peptide directly to the gastrointestinal tract, making it particularly relevant for gut-focused research. Studies have explored oral BPC-157 in models of gastric ulcers, inflammatory bowel conditions, and intestinal damage. Oral Peptide Delivery BPC-157’s gastric stability makes it uniquely suited to research into oral peptide administration — a field with broad implications for non-invasive peptide delivery. Worth Noting The oral format is ideal for research protocols specifically requiring oral administration, or for comparing oral versus injectable peptide delivery routes. For research use only. Not intended for human consumption. Not approved by the FDA or TGA.
